Navigation Links
Risks and benefits of antipsychotics in children and adolescents
Date:9/1/2008

age 15.5), no significant differences were found in the reduction on any symptomatology scale in patients treated with risperidone, quetiapine, or olanzapine for six months (Castro-Fornieles et al., in press).

Metabolic and hormonal safety

Childhood obesity is increasing worldwide and is associated with an increase in other cardiovascular risk factors in childhood, such as dyslipidemia, hypertension, and impaired glucose tolerance (Weiss et al., 2004). In addition, there is increasing concern about second-generation antipsychotics having metabolic side effects such as weight gain, hyperglycaemia, and dyslipidemia in the paediatric population (Correll, 2008). In the first study directly comparing weight gain and other metabolic and hormonal risk factors after treatment with 3 different new-generation antipsychotics in children and adolescents (mean age 15.2 years), it was shown that, after 6 months, body mass index scores and total cholesterol levels increased significantly, with 33 patients (50.0%) with no previous antipsychotic exposure showing significant weight gain (Fraguas et al., in press). The number of patients at risk for adverse health outcomes increased from 11 (16.7%) to 25 (37.9%). These changes in metabolic parameters were different for the different antipsychotics studied.

In the naturalistic study conducted by our group in early-onset psychosis patients, weight gain was also greater with olanzapine than with risperidone or quetiapine (Castro-Fornieles et al., in press). Weight gain in children raises the concern that, if treated for long periods, these patients may be at higher risk of insulin resistance, diabetes, hypertension, and cardiovascular disease in the future. If drugs likely to induce weight gain must be used, compensatory behavioural or pharmacological approaches should be implemented (Laita et al. 2007; Correll, 2007). A further concern with antipsychotic treatment in paediatric populations is the hyperprolactine
'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
43-140-557-340
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. NAS report offers new tools to assess health risks from chemicals
2. Less Arctic ice means higher risks, experts warn
3. Energy drinks may pose risks for people with high blood pressure, heart disease
4. Fresh-cut produce washing practices can minimize food-borne illness risks
5. Turtle studies suggest health risks from environmental contaminants
6. Too much or too little weight gain poses risks to pregnant mothers, babies
7. Baker Institute study, conference weigh risks for global energy markets
8. Tufts University biologists link Huntingtons disease to health benefits in young
9. The benefits of 80 million years without sex
10. New data shows benefits of MitraClip for patients with mitral regurgitation
11. RAND paper finds diesel, hybrid vehicles can provide more societal benefits than gas-powered autos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of the "Facial Recognition Market ... User - Global Forecast to 2020" report ... years, have seen facial recognition technology become more ... technology to gain traction and investment from the ...
(Date:5/25/2015)... , May 25, 2015  Australia,s market for wearable ... although 2014 saw the advent of several trials and ... April 2015 is expected to ignite interest in wearables ... Australia . This in turn will ... and drive new partnerships amongst vendors and distributors. ...
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year.  The course will focus ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... Providing food security, one of the greatest challenges ... the developing world, where crop destruction by drought, disease ... risk of hunger. Scientists at the University of ... on cowpea, a protein-rich legume crop of immense importance ...
... NJ Uncover the neural communication links involved in ... it may become possible to reverse the breakdown of ... multiple sclerosis, spinal cord injuries, diabetes and cancers of ... the New Jersey Commission on Spinal Cord Injury and ...
... 14 satellites currently in orbit and the National Aeronautics ... been able to observe the Earths environment to help ... The use of remote sensing technology aids specialists ... common and deadly infectious diseases today such as Ebola, ...
Cached Biology News:UCR researchers awarded nearly $1.7M to develop improved cowpea varieties 2UCR researchers awarded nearly $1.7M to develop improved cowpea varieties 3UCR researchers awarded nearly $1.7M to develop improved cowpea varieties 4Rutgers scientist's research reveals critical knowledge about the nervous system 2NASA technology helps predict and prevent future pandemic outbreaks 2
(Date:6/1/2015)... Corporation (NASDAQ: NEOG ) announced today that it has ... food testing laboratory based in southwest India ... base for the company,s new operations in India ... was incorporated in 1990, and its business has grown to ... testing for major hotels and restaurants in its home region, ...
(Date:6/1/2015)... - Resverlogix Corp. (TSX: RVX) (the "Company") today announced ... ERA-EDTA Congress in London, England ... Epigenetic BET-Inhibitor, on Key Renal Parameters in Subjects with ... a Post-hoc Analysis of Patients from the ASSERT, SUSTAIN ... Kam Kalantar-Zadeh , Professor and Chief, Division of Nephrology and Hypertension at ...
(Date:6/1/2015)...  Berg, a biopharmaceutical company committed to uncovering health ... from its trials using its cancer drug BPM 31510 ... triple negative breast cancer, at the 51 st ... (ASCO), May 29 – June 2 in ... one of the first cancer drugs guided in development ...
(Date:6/1/2015)... 2015 Shire plc (LSE: SHP, ... participating in the Jefferies 2015 Global Healthcare Conference in ... June 2, 2015. Jeff Poulton , Chief Financial ... at 10:00 a.m. ET (3:00 p.m. BST). ... Presentations and Webcasts section of Shire,s Investor website at ...
Breaking Biology Technology:Neogen acquires India food safety company 2Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 2Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 3Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 4Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3
... 15, 2011 diaDexus, Inc. (OTC Bulletin Board: ... commercialization of patent-protected in vitro diagnostic products addressing ... the second quarter of 2011. Total revenues for ... 45% growth over total revenues of $2.6 million for the ...
... 3-V Biosciences, Inc. announced today the appointment of ... (Logo:   http://photos.prnewswire.com/prnh/20100513/LA04336LOGO ) "We are ... of the 3-V senior management team," said Merdad V. ... experience in drug discovery and development, as well as ...
... CA (July 1, 2011) After Fukushima, it is now ... - from cradle to grave. If nuclear waste management is ... countries will reject nuclear power as an energy choice, according ... the Atomic Scientists , published by SAGE. According to ...
Cached Biology Technology:diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 2diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 3diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 4diaDexus, Inc. Reports 45% Year-Over-Year Revenue Growth for 2011 Second Quarter 53-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer 2Nuclear waste requires cradle-to-grave strategy 2Nuclear waste requires cradle-to-grave strategy 3
N,N'-Methylene-bis-acrylamide, Ultra Pure...
Bovine Calf Serum...
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
...
Biology Products: